Every company has a story to tell. Let us tell yours.

Your reputation is the key to attracting investors and business partners.

We can help you stand out from the crowd.

OPUS Biotech has an extensive network of contacts built on decades of experience working with life sciences industry leaders, news media, investors and government officials.

Our Focus

We work with emerging companies to tell their stories of innovation, perseverance and value.

We create strategies for connecting with critical constituencies such as news media, opinion leaders, government officials, investors, and business partners.

We help companies, their people and technology stand out from the crowd.

How We Work

Our cost-effective representation will

Raise Your Profile

Expand Your Contacts

Define Your Brand

What We Do

Our communications expertise is grounded in the ability to write clear, concise and compelling copy, forming the foundation for the services we provide, such as:

Public and Investor Relations

Outreach to Investors, Business Partners, Regulatory Affairs Experts and Advocacy Groups

CEO and Company Reputation Management and Government Affairs Support


Reputation management

Ongoing strategic media and communications counsel

Press releases writing and editing

Media outreach

Message development

Investor outreach preparation and presentations

Website reviews

Local, State and Federal lobbying

R & D Bioethics program development

Who We Are

Eramian300x300ltDaniel Eramian served as the first vice president of communications for the Biotechnology Innovation Organization (BIO) during the industry’s transformation from fascinating science to global health care innovator. He also managed the challenging communications and investor relations needs of public and private biotech companies and served on their management boards. Eramian has also been chief spokesman for two national federal agencies, the Department of Justice and the Small Business Administration. He began his career as a newspaper reporter and editor. Eramian also was a Chief of Staff in the Massachusetts State Senate.


ccraig300x300revCharles Craig has been on the front lines of the biotech revolution as president of Georgia Bio and as a writer, editor and communicator for the Biotechnology Innovation Organization (BIO), BioWorld Today and annual Ernst & Young Global Biotechnology Report. During his 30-year career, he also worked as a writer and editor for mainstream newspapers, magazines, and television news. In addition, Craig has a Master of Arts degree in bioethics from Emory University, writes and lectures on health care and clinical research ethics, and has experience building a framework for addressing bioethical issues. 

How to Reach


Daniel Eramian   425-306-8716

San Francisco

P.J. Johnston   415-923-8944


Charles Craig   404-245-0591